Corticosteroids inhibit both NFkB signaling and activation of the NLRP3 inflammasome (34), pathways involved in dry eye associated inflammation and that increase in DS activated monocytes (30, 35). This evidence concerns the gene NLRP3 and Dravet syndrome.